UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (178) 178
life sciences & biomedicine (157) 157
humans (143) 143
oncology (117) 117
female (109) 109
male (101) 101
middle aged (94) 94
aged (86) 86
adult (66) 66
physics (65) 65
lung cancer (56) 56
lung neoplasms - drug therapy (52) 52
biological and medical sciences (47) 47
medical sciences (46) 46
lung neoplasms - pathology (44) 44
aged, 80 and over (42) 42
carcinoma, non-small-cell lung - drug therapy (38) 38
mutation (36) 36
respiratory system (36) 36
cancer (35) 35
chemistry (31) 31
electricity (31) 31
tumors (30) 30
measuring (29) 29
testing (29) 29
treatment outcome (29) 29
carcinoma, non-small-cell lung - pathology (28) 28
chemotherapy (28) 28
performing operations (28) 28
transporting (28) 28
animals (27) 27
lung cancer, non-small cell (26) 26
analysis (25) 25
patients (25) 25
lung neoplasms - mortality (24) 24
metallurgy (24) 24
neoplasm staging (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (23) 23
antineoplastic agents - therapeutic use (21) 21
carcinoma, non-small-cell lung - mortality (21) 21
care and treatment (21) 21
non-small cell lung cancer (21) 21
research (21) 21
human necessities (20) 20
lung neoplasms - genetics (20) 20
protein kinase inhibitors - therapeutic use (19) 19
tyrosine (19) 19
general tagging of cross-sectional technologies spanning over several sections of the ipc (18) 18
general tagging of new technological developments (18) 18
japan (18) 18
medicine & public health (18) 18
non-small cell lung carcinoma (18) 18
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (18) 18
genetic aspects (16) 16
investigating or analysing materials by determining theirchemical or physical properties (16) 16
pneumology (16) 16
retrospective studies (16) 16
tumor cells, cultured (16) 16
tumors of the respiratory system and mediastinum (16) 16
antineoplastic agents (15) 15
prognosis (15) 15
rats (15) 15
basic electric elements (14) 14
electric communication technique (14) 14
heating (14) 14
lung neoplasms - diagnosis (14) 14
optics (14) 14
blasting (13) 13
calculating (13) 13
computing (13) 13
counting (13) 13
epidermal growth factor (13) 13
hematology, oncology and palliative medicine (13) 13
lighting (13) 13
mechanical engineering (13) 13
oncology, experimental (13) 13
physical sciences (13) 13
protein-tyrosine kinase (13) 13
pulmonary/respiratory (13) 13
respiratory tract diseases (13) 13
survival rate (13) 13
testing static or dynamic balance of machines orstructures (13) 13
testing structures or apparatus not otherwise provided for (13) 13
weapons (13) 13
antineoplastic combined chemotherapy protocols - adverse effects (12) 12
cancer therapies (12) 12
clinical trials (12) 12
combustion engines (12) 12
disease-free survival (12) 12
epidermal growth factor receptors (12) 12
hot-gas or combustion-product engine plants (12) 12
multivariate analysis (12) 12
pharmacology. drug treatments (12) 12
pictorial communication, e.g. television (12) 12
receptor, epidermal growth factor - genetics (12) 12
research article (12) 12
technologies or applications for mitigation or adaptation againstclimate change (12) 12
adenocarcinoma - pathology (11) 11
climate change mitigation technologies related totransportation (11) 11
erbb receptors - genetics (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2017, Volume 390, Issue 10089, pp. 29 - 39
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Single-Blind Method | Lung Neoplasms - drug therapy | Pyrazoles - therapeutic use | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | Protein Kinase Inhibitors - adverse effects | Piperidines - blood | Brain Neoplasms - secondary | Pyridines - adverse effects | Carcinoma, Non-Small-Cell Lung - secondary | Neoplasm Grading | Antineoplastic Agents - adverse effects | Pyrazoles - blood | Aged, 80 and over | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Adult | Female | Carbazoles - blood | Pyrazoles - adverse effects | Pyridines - therapeutic use | Carcinoma, Non-Small-Cell Lung - pathology | Carbazoles - adverse effects | Lung Neoplasms - enzymology | Kaplan-Meier Estimate | Receptor Protein-Tyrosine Kinases - metabolism | Protein Kinase Inhibitors - blood | Pyridines - blood | Piperidines - therapeutic use | Protein Kinase Inhibitors - therapeutic use | Piperidines - adverse effects | Antineoplastic Agents - blood | Aged | Carbazoles - therapeutic use | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Medical colleges | Respiratory agents | Care and treatment | Lymphomas | Lung cancer, Non-small cell | Product development | Pharmaceutical industry | Analysis | Toxicity | Funding | Lung cancer | Central nervous system | Metastasis | Kinases | Evidence-based medicine | Recruitment | Motivation | Audio frequencies | Safety | Toxic diseases | Drug dosages | Protein-tyrosine kinase | Effectiveness | Data processing | Group dynamics | Patients | Survival | Lymphoma | Chemotherapy | Inhibitors | Interactive systems | Death | Mutation | Cancer | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 01/2020, Volume 382, Issue 1, pp. 41 - 50
Journal Article
The lancet oncology, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. 1147 - 1157
Journal Article
Cancer science, ISSN 1347-9032, 09/2019, Volume 110, Issue 9, pp. 2884 - 2893
EGFR mutation | non‐small‐cell lung cancer | tyrosine kinase inhibitor | acquired resistance | osimertinib | Life Sciences & Biomedicine | Oncology | Science & Technology | Japan - epidemiology | Lung Neoplasms - drug therapy | Lung Neoplasms - mortality | Humans | Middle Aged | ErbB Receptors - genetics | Diarrhea - epidemiology | Lung Neoplasms - pathology | Lung Diseases, Interstitial - chemically induced | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | Diarrhea - chemically induced | Paronychia - epidemiology | Antineoplastic Agents - adverse effects | Exanthema - chemically induced | Aged, 80 and over | Adult | Aniline Compounds - administration & dosage | Lung Diseases, Interstitial - epidemiology | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Paronychia - chemically induced | ErbB Receptors - antagonists & inhibitors | Administration, Oral | Carcinoma, Non-Small-Cell Lung - genetics | Survival Rate | Carcinoma, Non-Small-Cell Lung - mortality | Disease Progression | Exanthema - epidemiology | Protein Kinase Inhibitors - administration & dosage | Drug Resistance, Neoplasm - genetics | Acrylamides - administration & dosage | Progression-Free Survival | Survival Analysis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Aniline Compounds - adverse effects | Acrylamides - adverse effects | Drug Resistance, Neoplasm - drug effects | Tyrosine | Medical research | Chemotherapy | Analysis | Medicine, Experimental | Development and progression | Respiratory tract diseases | Lung cancer, Non-small cell | Cancer | Epidermal growth factor receptors | Research funding | Lung cancer | Lung diseases | Clinical trials | Diarrhea | Non-small cell lung carcinoma | Cancer therapies | Studies | Epidermal growth factor | Platinum | Skin | Mutation | Safety | Protein-tyrosine kinase | Pharmaceuticals | Index Medicus | Original
Journal Article
Journal Article
Cancer science, ISSN 1347-9032, 03/2016, Volume 107, Issue 3, pp. 353 - 358
lung cancer | Carcinoembryonic antigen | epidermal growth factor receptor tyrosine kinase inhibitor | massively parallel DNA sequencer | circulating tumor DNA | Epidermal growth factor receptor tyrosine kinase inhibitor | Massively parallel DNA sequencer | Lung cancer | Circulating tumor DNA | Life Sciences & Biomedicine | Oncology | Science & Technology | Lung Neoplasms - genetics | Lung Neoplasms - drug therapy | Humans | Middle Aged | ErbB Receptors - genetics | Drug Resistance, Neoplasm | Male | Antineoplastic Agents - therapeutic use | Mutation, Missense | Biomarkers, Tumor - blood | DNA, Neoplasm - blood | DNA Mutational Analysis | Protein Kinase Inhibitors - therapeutic use | Aged, 80 and over | Female | Aged | Antineoplastic Agents - pharmacology | Biomarkers, Tumor - genetics | Lung Neoplasms - blood | Protein Kinase Inhibitors - pharmacology | DNA, Neoplasm - genetics | Tyrosine | Development and progression | Epidermal growth factor | Multiprocessing | Analysis | DNA | Phenols | Genetic research | Genetic aspects | Nucleotide sequencing | CEA (Oncology) | Cancer | DNA sequencing | Plasma | Disease | Laboratories | Cytotoxicity | Gene deletion | Kinases | Clonal deletion | Protein-tyrosine kinase receptors | Protein-tyrosine kinase | Deoxyribonucleic acid--DNA | Subpopulations | Nucleotide sequence | Epidermal growth factor receptors | Invasiveness | Patients | Studies | Genotyping | Biopsy | Mutation | Genetic testing | Cytotoxic agents | Tumors | Index Medicus | Original
Journal Article